BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17894021)

  • 1. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report.
    Barzilai O; Sherer Y; Ram M; Izhaky D; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Jun; 1108():567-77. PubMed ID: 17894021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200.
    Lidar M; Lipschitz N; Langevitz P; Barzilai O; Ram M; Porat-Katz BS; Pagnoux C; Guilpain P; Sinico RA; Radice A; Bizzaro N; Damoiseaux J; Tervaert JW; Martin J; Guillevin L; Bombardieri S; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():649-57. PubMed ID: 19758211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.
    Sohn MJ; Cho JM; Moon JS; Ko JS; Yang HR
    Medicine (Baltimore); 2018 Sep; 97(38):e12380. PubMed ID: 30235701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.
    Levine H; Balicer RD; Rozhavski V; Halperin T; Shreberk M; Davidovitch N; Huerta-Hartal M; Ankol OE
    Ann Epidemiol; 2012 Nov; 22(11):783-8. PubMed ID: 22831994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antibodies to cytomegalovirus and Epstein-Barr virus in patients with autism spectrum disorder.
    Valayi S; Eftekharian MM; Taheri M; Alikhani MY
    Hum Antibodies; 2017; 26(3):165-169. PubMed ID: 29689713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV.
    Tcherniaeva I; den Hartog G; Berbers G; van der Klis F
    J Immunol Methods; 2018 Nov; 462():1-8. PubMed ID: 30056034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections.
    O'Neill HJ; Shirodaria PV
    J Infect; 1992 May; 24(3):301-9. PubMed ID: 1318341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation.
    Drouet E; Chapuis-Cellier C; Bosshard S; Verniol C; Niveleau A; Touraine JL; Garnier JL
    Clin Exp Immunol; 1999 Dec; 118(3):465-72. PubMed ID: 10594569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
    Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
    Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
    Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.
    Rasmussen NS; Draborg AH; Nielsen CT; Jacobsen S; Houen G
    Scand J Rheumatol; 2015; 44(2):143-9. PubMed ID: 25562120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
    Obel N; Høier-Madsen M; Kangro H
    APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
    Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.
    Holder B; Miles DJ; Kaye S; Crozier S; Mohammed NI; Duah NO; Roberts E; Ojuola O; Palmero MS; Touray ES; Waight P; Cotten M; Rowland-Jones S; van der Sande M; Whittle H
    PLoS One; 2010 Nov; 5(11):e14013. PubMed ID: 21103338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.